WuXi AppTec, CNE100003F19

WuXi AppTec stock reports strong H1 growth after guidance raise

Published on 10/07/2026 at 10:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

WuXi AppTec stock delivered RMB 28.897 billion in H1 revenue, up 38.93 percent, in the 2026 interim period. Guidance rose to RMB 58.5-60.5 billion.

WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.
WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec stock (ISIN CNE100003F19) was last at HKD 218.40 on the Hong Kong Stock Exchange on October 7, 2026 at 3:48 p.m. HKT, down 0.09 percent from the prior close. The company enters the next reporting phase after raising its 2026 revenue guidance to RMB 58.5-60.5 billion.

H1 revenue reaches RMB 28.897 billion

According to GMT EIGHT on September 16, 2026, WuXi AppTec reported H1 2026 operating revenue of RMB 28.897 billion, up 38.93 percent year over year. Net profit attributable to shareholders reached RMB 11.08 billion, an increase of 29.43 percent over the same period.

The same report said continuing-operations backlog stood at RMB 59.77 billion at the end of June 2026, up 23.6 percent year over year. That backlog gives the revenue guidance a measurable operational base, although conversion still depends on customer project timing and delivery capacity.

Guidance reset changes the earnings frame

GMT EIGHT reported that the company lifted its 2026 revenue range from RMB 51.3-53.0 billion to RMB 58.5-60.5 billion. Continuing-operations growth guidance increased from 18-22 percent to 35-39 percent, while adjusted net profit margin guidance remained stable.

The small-molecule development and manufacturing business was the sharpest quantified growth engine. H1 revenue reached RMB 14.99 billion, up 72.7 percent year over year, according to GMT EIGHT.

Consensus sits near the market price

Investing.com lists a Strong Buy consensus from 24 analysts, with an average 12-month price target of HKD 219.47, a high estimate of HKD 262.79611423 and a low estimate of HKD 139.03441011. Against the HKD 218.40 price on October 7, 2026, the average target lies 0.49 percent above the price.

The market is therefore pricing the upgraded outlook with limited consensus upside at the average target, while the wide target range leaves valuation sensitivity to execution and policy conditions. A September 16, 2026 review by Futunn.com identified weaker demand, policy changes, development execution and competition as factors that could affect the outlook.

WuXi AppTec stock stays near yearly high

WuXi AppTec stock was last at HKD 218.40 on the Hong Kong Stock Exchange on October 7, 2026 at 3:48 p.m. HKT. The 52-week range was HKD 50.15 to HKD 219.20, and market capitalization stood at HKD 632.6 billion.

WuXi AppTec stock facts

  • Company: WuXi AppTec Co., Ltd.
  • ISIN: CNE100003F19
  • Ticker: 2359
  • Trading venue: Hong Kong Stock Exchange
  • Price (as of October 7, 2026, 3:48 p.m. HKT): HKD 218.40
  • Market capitalization: HKD 632.6 billion (as of October 7, 2026)
  • 52-week range: HKD 50.15-219.20 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Biotechnology and Medical Research

More news and analyses on WuXi AppTec stock

Disclaimer...

en | CNE100003F19 | WUXI APPTEC | boerse | 70253757 | bgmi